Esplanade Ventures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Executive Officer, Director)in
BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)inLouis Samson(Director)
Co-investorsBattery VenturesBreyer CapitalDigiTx Partners LLCInsight PartnersLRVHealthNew Leaf Venture Partners+4 more
Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind.
Digital HealthHealthtechMedical DevicesMental HealthLafayette, US
Richard Hanbury(Founder)in
Co-investorsCheckmate Capital Group LLCClick VenturesFlucas VenturesHarmonix FundHealthtech CapitalMarram Ventures+5 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bone Health Technologies
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.